SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Fifth Street Finance Corp. and a Lead Plaintiff Deadline of November 30, 2015 – FSC

NEW YORK, Oct. 20, 2015 (GLOBE NEWSWIRE) — The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Fifth Street Finance Corp. (“Fifth Street Finance” or the “Company”) (Nasdaq:FSC) common stock between July 7, 2014 and February 6, 2015.

Click here to learn about the case: There is no cost or obligation to you.

The complaint alleges that during the Class Period, defendants engaged in a fraudulent scheme and course of business designed to artificially inflate Fifth Street Finance’s assets and investment income in order to increase its revenue. Specifically, the complaint alleges that, among other things, defendants pushed Fifth Street Finance into increasingly risky, speculative investments at unsustainable leverage levels, delayed writing down impaired investments in order to create the appearance of increasing revenues for Fifth Street Finance, and systematically overstated the income generated by Fifth Street Finance’s investments and the fair value of its portfolio, while simultaneously providing investors and the market with false and misleading portrayals of Fifth Street Finance’s business trends and expected performance.

If you suffered a loss in Fifth Street Finance you have until November 30, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email, by telephone at 212.425.1140, or visit

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880